Methotrexate is a commonly used medication for inflammatory and autoimmune disorders. Dermatologic literature recommends frequent laboratory monitoring due to the potential of serious side effects although data supporting this recommendation is lacking. In this study, we aimed to identify the incidence and timing of laboratory abnormalities in a cohort of patients prescribed low-dose methotrexate during their first year of therapy.
Details
Title
Low-dose methotrexate safety in dermatologic disease: incidence and timing of laboratory abnormalities during the first year of therapy
Creator
Greiling, Teri : Oregon Health and Science University Hajar, T. : Oregon Health and Science University Latour, E.J. : Oregon Health and Science University Haynes, D. : Oregon Health and Science University Topham, C. : Oregon Health and Science University Hill, E. : Oregon Health and Science University Strunck, J. : Oregon Health and Science University Simpson, E.L. : Oregon Health and Science University
Meeting Name
Research Week, Oregon Health and Science University, 2020
